PUS10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.875900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.653390E-01
Normal-vs-Stage2
4.399100E-03
Normal-vs-Stage3
1.733990E-01
Normal-vs-Stage4
2.411600E-01
Stage1-vs-Stage2
5.407800E-01
Stage1-vs-Stage3
2.130800E-01
Stage1-vs-Stage4
7.373600E-01
Stage2-vs-Stage3
3.000000E-01
Stage2-vs-Stage4
3.608800E-01
Stage3-vs-Stage4
3.465800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.444300E-03
Normal-vs-AfricanAmerican
1.354420E-01
Normal-vs-Asian
1.498280E-02
Caucasian-vs-AfricanAmerican
6.752800E-01
Caucasian-vs-Asian
1.460750E-01
AfricanAmerican-vs-Asian
2.410400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.684100E-03
Normal-vs-Female
2.416600E-01
Male-vs-Female
9.452600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.196200E-01
Normal-vs-Age(41-60Yrs)
1.550350E-02
Normal-vs-Age(61-80Yrs)
1.857520E-03
Normal-vs-Age(81-100Yrs)
3.499900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.881200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.345200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.239800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.584500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.381400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.308400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.916000E-03
Normal-vs-Daily Drinker
4.341900E-03
Normal-vs-Weekly Drinker
1.467750E-02
Normal-vs-Occasional Drinker
2.610400E-01
Normal-vs-Social Drinker
2.551600E-01
Non Drinker-vs-Daily Drinker
3.423000E-01
Non Drinker-vs-Weekly Drinker
4.622400E-01
Non Drinker-vs-Occasional Drinker
6.670800E-01
Non Drinker-vs-Social Drinker
7.419400E-01
Daily Drinker-vs-Weekly Drinker
9.464000E-01
Daily Drinker-vs-Occasional Drinker
1.781770E-01
Daily Drinker-vs-Social Drinker
2.127200E-01
Weekly Drinker-vs-Occasional Drinker
2.657600E-01
Weekly Drinker-vs-Social Drinker
2.959800E-01
Occasional Drinker-vs-Social Drinker
9.219400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.490200E-02
Normal-vs-Grade 2
1.209700E-02
Normal-vs-Grade 3
4.059900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.458400E-02
Grade 1-vs-Grade 3
2.105600E-02
Grade 1-vs-Grade 4
8.490200E-02
Grade 2-vs-Grade 3
6.954400E-01
Grade 2-vs-Grade 4
1.209700E-02
Grade 3-vs-Grade 4
4.059900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.636600E-03
Normal-vs-NonDiabetic
2.284400E-01
Diabetic-vs-NonDiabetic
8.829000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.941900E-02
Normal-vs-NoPancreatitis
2.313200E-01
Pancreatitis-vs-NoPancreatitis
9.226600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.878300E-03
Normal-vs-N1
3.744100E-03
N0-vs-N1
3.095000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.450000E-01
Normal-vs-TP53-NonMutant
1.578440E-02
TP53-Mutant-vs-TP53-NonMutant
5.958400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
